European Journal of Nutrition

, Volume 52, Issue 2, pp 771–778 | Cite as

Low-fat dairy, but not whole-/high-fat dairy, consumption is related with higher serum adiponectin levels in apparently healthy adults

  • Kaijun Niu
  • Yoritoshi Kobayashi
  • Lei Guan
  • Haruki Monma
  • Hui Guo
  • Yufei Cui
  • Atsushi Otomo
  • Masahiko Chujo
  • Ryoichi Nagatomi
Original Contribution

Abstract

Purpose

Although previous studies suggested that higher low-fat dairy consumption lower the risk of type 2 diabetes, the mediating factors are not well understood. Higher baseline adiponectin levels are related with a lower risk of type 2 diabetes. This study evaluated whether low-fat dairy is related with adiponectin in apparently healthy adults.

Methods

We investigated a cross-sectional (n = 938) and one-year longitudinal (n = 759) relationship between low-fat and whole-/high-fat dairy (both including cow’s milk and yogurt) and adiponectin. Dairy consumption was assessed with a validated food frequency questionnaire. Serum adiponectin was measured by using a specific sandwich enzyme-linked immunosorbent assay.

Results

In the cross-sectional analysis, the geometric means (95 % confidence intervals [95 % CIs]) of log-transformed adiponectin related with the low-fat dairy categories were 7.27 (6.80–7.77) for the lowest category, 7.67 (7.09–8.31) for the middle category, and 8.40 (7.73–9.13) for the highest category (p < 0.001) after adjustment for potential confounders (including all lifestyle factors). In the longitudinal analysis, repeated-measures ANCOVA adjusted for confounding factors showed a significant time-by-categories (categories of low-fat dairy) interaction in the change of adiponectin. In contrast, no significant relationship was found between the whole-/high-fat dairy categories and adiponectin.

Conclusions

This study has shown that higher consumption of low-fat dairy, but not of whole-/high-fat dairy, is related with higher levels of adiponectin and with the change of adiponectin level at the one-year follow-up. These results suggest that the consumption of low-fat dairy may have a beneficial effect on serum adiponectin levels.

Keywords

Low-fat dairy Adiponectin Diabetes risk factors Insulin resistance 

Notes

Acknowledgments

We gratefully acknowledge all the men and women who participated in the study and Sendai Oroshisho Center for the possibility to perform the study. This study was supported by a Grant-in-Aid for “Knowledge Cluster Initiative” from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Conflict of interest

All the authors have no conflicts of interest exists to disclose.

References

  1. 1.
    Ebringer L, Ferencik M, Krajcovic J (2008) Beneficial health effects of milk and fermented dairy products–review. Folia Microbiol (Praha) 53:378–394CrossRefGoogle Scholar
  2. 2.
    Zemel MB (2005) The role of dairy foods in weight management. J Am Coll Nutr 24:537S–546SGoogle Scholar
  3. 3.
    Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB (2005) Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165:997–1003CrossRefGoogle Scholar
  4. 4.
    Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE, Manson JE (2006) A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29:1579–1584CrossRefGoogle Scholar
  5. 5.
    Trujillo ME, Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27:762–778Google Scholar
  6. 6.
    Sharma AM, Staels B (2007) Review: peroxisome proliferator-activated receptor gamma and adipose tissue–understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92:386–395CrossRefGoogle Scholar
  7. 7.
    Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697–10703CrossRefGoogle Scholar
  8. 8.
    Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefGoogle Scholar
  9. 9.
    Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946CrossRefGoogle Scholar
  10. 10.
    Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188CrossRefGoogle Scholar
  11. 11.
    Guo H, Niu K, Monma H, Kobayashi Y, Guan L, Sato M, Minamishima D, Nagatomi R (2010 Sep 27. [Epub ahead of print]) Association of Japanese dietary pattern with serum adiponectin concentration in Japanese adult men. Nutr Metab Cardiovasc Dis Available at doi: 10.1016/j.numecd.2010.06.006
  12. 12.
    Sasaki S (2005) Serum Biomarker-based Validation of a Brief-type Self-administered Diet History Questionnaire for Japanese Subjects, The Study Group of Ministry of Health, Labor and Welfare of Japan, Tanaka H, chairman, “A research for assessment of nutrition and dietary habit in “Kenko Nippon 21”. Tokyo:10-42 (in Japanese)Google Scholar
  13. 13.
    Sasaki S (2010) EBNJAPAN site. The nutrient data file for the Brief-type Self-administered Diet History Questionnaire (Updated April, 2010). http://www.ebnjapan.org/developer/info_bdhq.html. Accessed 07 May 2012
  14. 14.
    Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefGoogle Scholar
  15. 15.
    Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM (2007) Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med 357:2189–2194CrossRefGoogle Scholar
  16. 16.
    Yannakoulia M, Yiannakouris N, Melistas L, Kontogianni MD, Malagaris I, Mantzoros CS (2008) A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metabolism 57:824–830CrossRefGoogle Scholar
  17. 17.
    Hui X, Lam KS, Vanhoutte PM, Xu A (2011) Adiponectin and cardiovascular health: an update. Br J Pharmacol 165:574–590CrossRefGoogle Scholar
  18. 18.
    Kizer JR, Arnold AM, Jenny NS, Cushman M, Strotmeyer ES, Ives DG, Ding J, Kritchevsky SB, Chaves PH, Hirsch CH, Newman AB (2011) Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci 66:1100–1107CrossRefGoogle Scholar
  19. 19.
    Kizer JR, Arnold AM, Strotmeyer ES, Ives DG, Cushman M, Ding J, Kritchevsky SB, Chaves PH, Hirsch CH, Newman AB (2011) Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci 65:1208–1214Google Scholar
  20. 20.
    Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP, Hwang JJ, Yang WS (2009) The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 108:353–366CrossRefGoogle Scholar
  21. 21.
    Shinmura K (2010) Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease. Heart Fail Rev 15:457–466CrossRefGoogle Scholar
  22. 22.
    Wennersberg MH, Smedman A, Turpeinen AM, Retterstol K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009) Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr 90:960–968CrossRefGoogle Scholar
  23. 23.
    Zemel MB, Sun X (2008) Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr 138:1047–1052Google Scholar
  24. 24.
    Zemel MB (2003) Role of dietary calcium and dairy products in modulating adiposity. Lipids 38:139–146CrossRefGoogle Scholar
  25. 25.
    Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L (2010) Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6:71–82CrossRefGoogle Scholar
  26. 26.
    Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T, Yamamoto Y, Noguchi M, Kusakabe T, Tomita T, Fujikura J, Ebihara K, Hosoda K, Sakaue H, Kobori H, Ham M, Lee YS, Kim JB, Saito Y, Nakao K (2010) Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism 59:1241–1251CrossRefGoogle Scholar
  27. 27.
    Espiritu DJ, Mazzone T (2008) Oxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity. Diabetes 57:2992–2998CrossRefGoogle Scholar
  28. 28.
    Sun X, Zemel MB (2006) Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond) 30:1341–1346CrossRefGoogle Scholar
  29. 29.
    Sun X, Zemel MB (2007) 1Alpha,25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production. Obesity (Silver Spring) 15:1944–1953CrossRefGoogle Scholar
  30. 30.
    Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez JA, Martinez-Gonzalez MA (2005) Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 82:972–979Google Scholar
  31. 31.
    Xiao Y, Cui J, Shi YH, Sun J, Wang ZP, Le GW (2010) Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice. Nutrition 26:1188–1194CrossRefGoogle Scholar
  32. 32.
    Council JD (2005) Milk data site. http://www.dairy.co.jp/milkdata/w_data10.html. Accessed 22 March 2012
  33. 33.
    Cook JR, Semple RK (2010) Hypoadiponectinemia–cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 95:1544–1554CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Kaijun Niu
    • 1
    • 2
  • Yoritoshi Kobayashi
    • 2
  • Lei Guan
    • 2
  • Haruki Monma
    • 2
  • Hui Guo
    • 2
  • Yufei Cui
    • 2
  • Atsushi Otomo
    • 2
  • Masahiko Chujo
    • 2
  • Ryoichi Nagatomi
    • 2
  1. 1.Department of EpidemiologySchool of Public Health, Tianjin Medical UniversityTianjinPeople’s Republic of China
  2. 2.Division of Biomedical Engineering for Health and WelfareTohoku University Graduate School of Biomedical EngineeringSendaiJapan

Personalised recommendations